Cargando…
Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients
Morbidity and mortality of lung cancer rank first in China and worldwide. Thus, noninvasive prognostic biomarkers are critical for clinicians to perform risk assessment in lung cancer patients prior to or during the course of treatment. In this study, we evaluated the prognostic value of preoperativ...
Autores principales: | Zhang, Xin, Zhang, Fengmin, Qiao, Wenbo, Zhang, Xiansheng, Zhao, Zhefeng, Li, Mingqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207876/ https://www.ncbi.nlm.nih.gov/pubmed/30417013 http://dx.doi.org/10.1155/2018/6804938 |
Ejemplares similares
-
ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma
por: Li, Changying, et al.
Publicado: (2015) -
Hyperglycemia is a strong predictor of poor prognosis in COVID-19
por: Liu, Sheng-ping, et al.
Publicado: (2020) -
Sexual Dimorphism in Hematocrit Response Following Red Blood Cell Transfusion of Critically Ill Surgical Patients
por: Pieracci, Fredric M., et al.
Publicado: (2012) -
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients
por: Shi, Qing, et al.
Publicado: (2017) -
Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer
por: Wang, Shuoshan, et al.
Publicado: (2023)